Summary.-Analysis of pathological data in the 10th year of follow-up of a multicentre trial of the management of operable breast cancer has confirmed the correlation of prognosis with tumour grade, tumour size and lymph-node status. For each factor examined there was no difference in survival between the 2 treatment groups ("watch policy" and radiotherapy) but patients in the WP group whose tumours were of Grade II or III or >2 cm, or with lymph-node metastases, had a greater chance of local recurrence. Cellular reaction had no relationship with prognosis, except in patients with Grade III tumours. The clinical relevance and application of these results are discussed.
Summary.-Analysis of pathological data in the 10th year of follow-up of a multicentre trial of the management of operable breast cancer has confirmed the correlation of prognosis with tumour grade, tumour size and lymph-node status. For each factor examined there was no difference in survival between the 2 treatment groups ("watch policy" and radiotherapy) but patients in the WP group whose tumours were of Grade II or III or >2 cm, or with lymph-node metastases, had a greater chance of local recurrence. Cellular reaction had no relationship with prognosis, except in patients with Grade III tumours. The clinical relevance and application of these results are discussed. June, 1970 . Details of the organization of the clinical aspects of the trial have been reported previously (Baum et al., 1972; Cancer Research Campaign Working Party, 1976) . In summary, patients presenting with clinical Stage I or Stage II carcinoma of the breast were randomized into a "watch policy" (WP) or radiotherapy (DXT) group. The WP patients had simple mastectomy alone (with careful observation of the axilla) and radiotherapy delayed until there was obvious progression or local recurrence of the disease. Patients in the DXT group underwent simple mastectomy with immediate radiotherapy. Over 1000 patients were admitted to each treatment group during the 5 years of accrual to the trial, and followup results in the 10th year have recently been reported (Cancer Research Campaign Working Party, 1980a) . Logrank analysis has failed to demonstrate a significant difference in survival between the groups, but there was a highly significant increased risk of local recurrence in the WP group. Although the trial was designed primarily to test the effectiveness of the two treatments, it was decided at the outset to include an examination of selected pathological factors for internal audit, and to make an assessment of their prognostic significance. This paper presents the results of the pathological study and discusses the place of pathological assessment in the future management of breast cancer.
THE Cancer Research Campaign Trial for early breast cancer was commenced in

MATERIALS AND METHODS
Women under 70 years of age with clinical
Stage I or II (Manchester) breast cancer were eligible for the trial, and between June 1970 and April 1975 , 2800 patients were entered.
In this multicentre trial, in which pathological material was collected at over 80 hospitals in the United Kingdom, Europe, Canada and New Zealand, it was not possible for every specimen to be processed centrally. All mastectomy specimens were therefore processed initially at the hospital of origin, and macroscopic details such as tumour size and the number of axillary lymph nodes, were entered on to the pathology section of the trial pro forma (Fig. 1) . Local pathologists were asked to prepare up to 4 paraffin blocks from each tumour, according to size, and to block separately each lymph node found in the axillary tail. These blocks, or multiple representative unstained sections, were then sent to the Central Trial Pathologists for detailed microscopic assessment, together with the pathology pro forma and a copy of the local pathologist's report. Paraffin sections of between 5 and 10 ,tm were stained with haematoxylin and eosin. Because of the many patients admitted to the trial, the microscopic assessments were carried out in two centres, Cambridge (GAG and GR) The method of grading invasive carcinoma was based on Bloom & Richardson (1957) which was derived from a modification by Patey & Scarff (1928) of Greenough's (1925) original method. The tumour grade was obtained by analysis of the following 3 histological features, a score of 1-3 being given within each category.
Tubule formation.-Where the major proportion of the tumour contained well formed tubules with clearly visible lumens, 1 point was given. When a moderate amount of the tumour contained tubules, 2 points were given. Where little or no tubule formation was seen, the cells growing in sheets or cords, the score was 3 points.
Nuclear pleomorphism.-An assessment was made of the variability in size and shape of the tumour nuclei. Tumours in which the nuclei were regular and showed little variation were given 1 point. A moderate degree of variability was scored as 2 points, and marked variation in size and shape was given 3 points.
Mitotic rate.-It was in this category that our method differed slightly from that of Bloom & Richardson (1957) who included hyperchromatic nuclei as well as mitoses as an indication of malignancy. We found it impossible to distinguish hyperchromatic nuclei from those which were pycnotic, and therefore assessed only the mitotic activity. This was graded as follows: less than 1 mitosis per high-power field (magnification 300) scored 1 point. One or 2 mitoses per HP field scored 2 points, and cases with more than 2 mitoses per HP field were given 3 points.
To case to case. In view of the large number of cases, and the non-standardized collection and preparation of histological sections, it was not possible to use a quantitative method. The assessment was, therefore, carried out on a semi-quantitative basis, using 4 degrees of intensity: Marked.-This was characterized by a wide diffuse band of inflammatory cells investing the whole of the periphery of the tumour, many cells in thickness. The tumour stroma also contained a heavy cellular infiltrate, so that the overall impression in these cases was that the inflammatory component was greater than the tumour component. Foci of lymphoid cells were also frequently seen in the adjacent connective tissue.
Moderate.-The reactions were graded as moderate when the whole tumour was surrounded by inflammatory cells which formed a diffuse band several cells wide, but not as extensive as that seen in a marked reaction. The stroma also contained a moderate infiltrate, but the mass of reactive cells never exceeded that of the tumour.
Slight.-The cellular infiltrate in a slight reaction consisted of a thin but definite diffuse band of inflammatory cells surrounding the whole tumour, with only occasional cells in the stroma. Cases with more intense focal infiltrates were also included in this category if the diffuse reaction at the periphery of the tumour could only be graded as slight.
Nil.-In nearly all tumours a few inflammatory cells can be found at the periphery. Included in this category, therefore, were all cases in which scanty foci of cells were found, but in which large parts of the periphery of the tumour were unassociated with any reaction.
Lymph-node status
The representative blocks or sections sent to the Trial Pathologists were examined carefully and the presence of lymph-node metastases recorded.
VERIFICATION
All these assessments, because of their subjective nature, were double-checked. This was achieved in two ways:
Cross-checking
Because of the large number of cases it was not always possible to carry out cross-checks, but in a substantial proportion, where the initial scoring was carried out by the original Trial Pathologists (CWE, GAG, GR) a second assessment was performed by a different pathologist (TZ) without knowing the initial results.
Double-checking
In those cases not cross-checked by TZ, a second assessment was carried out by the original pathologist, on a separate occasion, without knowing the initial results.
There was overall agreement in -85% of cases. Where there was disagreement, the sections were checked a third time, after which agreement was reached by concensus after discussion.
CLINICAL DETAILS
These have been reported in full previously (CRC Working Party, 1976 1980a (100) 1103 (100) 800 (70) 762 (69) 204 (18) 204 (18) 239 (21) 216 (20) 111 (10) 117 (11) 536 (47) 541 (49) reasons which are discussed in a separate communication (CRC Working Party, 1980b) . 
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( Fig. 12) . However, neither the Grade III (Fig. 13) 9-89** 3 35** recurrence than those whose nodes were l-7-0) (3.5-28) (1-4-8-2) negative (P<0-002). When the treatment policies were compared in the two node groups, the increased risk of local recure severity of the cell rence for patients who had not received the tumour, and the radiotherapy was greater for those with local recurrence in the involved nodes (hazard ratios 1-9 and 3-6 similar in both the mild for those with negative and positive nodes respectively) ( (Fig. 2) . However, tumour size may not be an independent factor, since there is a significant correlation between size and grade, Grade I tumours tending to be smaller than Grade III (Fig. 3) . In addition to measuring tumour size and sampling lymph nodes, the local pathologists were asked to assess the definition of the tumour edge, and note its attachment to deep fascia or skin. Curiously, the only one of these factors to influence prognosis is attachment to skin (Fig. 4) . There would seem to be little value in recording tumour definition in future studies, but attachment to deep fascia may be of practical importance to the surgeon.
Although assessment of histological tumour grade was advocated over 50 years ago as a useful prognostic factor in human breast cancer (Greenough, 1925; Patey & Scarff, 1928) it has never achieved universal acceptance. This is despite convincing evidence from Bloom that there is a clear correlation between a low grade of malignancy and better survival (Bloom, 1950a (Bloom, , b, 1962 in Grade I orly 2 were son, 1.957) the influence of grade persisting over 10-and 20-year follow-ups (Bloom & Field, 1971) . This association has been confirmed by several other studies (Wolff, 1966; Hamlin, 1.968; Champion et al., 1972; Elston et al., 1980) (Moore & Foote, 1949; Bloom et al., 1970; Ridolfi et al., 1977) and there has been speculation that the lymphoplasmacytic infiltrate represents an immunological host-defence mechanism (Berg, 1959) . Ridolfi et al. (1977) showed a significantly better survival at 10 years for medullary carcinoma (84%) than for non-medullary carcinoma (63%) whilst Bloom et al. (1970) demonstrated persistence of this effect in a 20-year follow-up (medullary 48% survival, non-medullary 16%). It has also been shown that, when the intensity of the cell infiltrates is assessed in all the tumours in a series, the prognosis is better with the more severe reaction (Black et al., 1955; Berg, 1959; Hamlin, 1968 Grade III tumours did patients in the severe-reaction group have a better survival (Fig. 11) . A precise comparison with medullary carcinoma cannot be made in this study, as histological typing was not undertaken. The closest approximation to medullary carcinoma is the subgroup composed of tumours of Grade II and III exhibiting a severe cell reaction; patients in this group did not have a better survival than other patients in the study (Fig. 13 ). This casts doubt on the contention that it is the lymphoplasmacytic infiltrate which is responsible for the relatively favourable prognosis of medullary carcinoma (Berg, 1959) . In this study the only predictive value of a severe cell reaction lies in the fact that its presence in a Grade III tumour improves the survival curve to that of the overall Grade II group (Fig. 12) . These results suggest, in common with some previous reports (Wolff, 1966; Blamey et al., 1979 ) that assessment of cell reaction provides limited prognostic information. The relationship between regional lymph-node metastasis and prognosis in breast cancer is well established (Cutler et al., 1969; Fisher et al., 1975) . Although the removal of axillary lymph nodes was discouraged, nodes were removed incidentally in 27% of cases. The survival curves confirm the significantly poorer prognosis of patients with histologically involved axillary nodes (Fig. 14) .
The most important point to emerge from follow-up in the tenth year of this trial is that, although there is no difference in survival between patients in the 2 treatment groups, those in the DXT group had fewer local recurrences (CRC Working Party, 1980a) . This poses a therapeutic dilemma. Should all patients undergoing simple mastectomy receive immediate post-operative radiotherapy to spare some 20-30% the anxiety of recognizing early failure of treatment, or could delayed radiotherapy eventually achieve the same degree of local control and thus spare most women unnecessary prophylactic radiotherapy? Consideration of the pathological data clarifies this problem. Local recurrence rates are significantly higher in the WP group for patients with Grade II and III tumours, but not Grade I tumours (Figs 7 and 8, Table III ) and for patients with histologically involved nodes (Table V) . Furthermore, within Grades II and III the risk tends to increase with increasing tumour size (Table III) . Immediate post-operative radiotherapy could certainly be recommended for patients with large Grade II or III tumours and histologically involved lymph nodes, whilst patients with small Grade I tumours and histologically negative nodes may not require adjuvant radiotherapy. Thus, for the first time, data are presented that may allow the clinician to select the extent of local therapy on the basis of histopathological criteria.
The purpose of the pathological part of the trial was to test certain established and potential pathological factors for prognostic significance. The results to date indicate that tumour size, histological grade and lymph-node metastasis provide significant markers of survival in breast cancer. This is in close agreement with the prospective study of Blamey et al. (1979) who have used these factors to devise an index of poor prognosis. They can also be used to determine local treatment policy. In planning the next generation of trials of adjuvant therapy, these factors should play an important part in the stratification of patients and therapy. more to acknowledge the very general financial support of the Cancer Research Campaign.
